- Home
- PMN vs SNES Comparison
PMN vs SNES Comparison
Compare PMN & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- SNES
- Stock Information
- Founded
- PMN 2004
- SNES 2004
- Country
- PMN Canada
- SNES United States
- Employees
- PMN N/A
- SNES N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- SNES Agricultural Chemicals
- Sector
- PMN Health Care
- SNES Industrials
- Exchange
- PMN Nasdaq
- SNES Nasdaq
- Market Cap
- PMN 22.3M
- SNES 21.0M
- IPO Year
- PMN N/A
- SNES 2016
- Fundamental
- Price
- PMN $0.46
- SNES $4.60
- Analyst Decision
- PMN Strong Buy
- SNES Strong Buy
- Analyst Count
- PMN 3
- SNES 1
- Target Price
- PMN $4.33
- SNES $10.00
- AVG Volume (30 Days)
- PMN 3.1M
- SNES 105.9K
- Earning Date
- PMN 11-13-2025
- SNES 11-11-2025
- Dividend Yield
- PMN N/A
- SNES N/A
- EPS Growth
- PMN N/A
- SNES N/A
- EPS
- PMN N/A
- SNES N/A
- Revenue
- PMN N/A
- SNES $2,093,000.00
- Revenue This Year
- PMN N/A
- SNES $130.53
- Revenue Next Year
- PMN N/A
- SNES $22.87
- P/E Ratio
- PMN N/A
- SNES N/A
- Revenue Growth
- PMN N/A
- SNES 36.89
- 52 Week Low
- PMN $0.38
- SNES $1.30
- 52 Week High
- PMN $1.59
- SNES $6.24
- Technical
- Relative Strength Index (RSI)
- PMN 43.27
- SNES 43.09
- Support Level
- PMN $0.39
- SNES $4.84
- Resistance Level
- PMN $0.45
- SNES $5.26
- Average True Range (ATR)
- PMN 0.04
- SNES 0.28
- MACD
- PMN 0.00
- SNES -0.03
- Stochastic Oscillator
- PMN 38.24
- SNES 0.00
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.